Table of Contents
Riyadh Pharma is expected to continue to focus its attention and investment on its Rx drugs rather than on OTC, a category in which the company has a stronger presence in the Kingdom of Saudi Arabia, but holds a very small presence outside the country’s borders. It is likely that the company will invest more in its core Rx business rather than in OTC products, in which it offers only two brands in the United Arab Emirates.
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Bayer AG, the third largest consumer health company in the world in 2016, continues its strong performance in over-the-counter (OTC) drugs. The company’s acquisition of Merck & Co in 2014 added important ...
Gastric Ulcers - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H1 2017, provides an overview of ...
Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, ...